| |
 |
|
Class Information
Number: 424/225.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Virus or component thereof > Hepatitis virus (e.g., infectious canine hepatitis virus, duck hepatitis virus, mouse hepatitis virus, etc.)
Description: Subject matter wherein the virus is a hepatitis virus.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7378234 |
Method for isolating hepatitis C virus peptides |
May. 27, 2008 |
| 7285289 |
Nanoparticle vaccines |
Oct. 23, 2007 |
| 7252827 |
Conserved motif of hepatitis C virus E2/NS1 region |
Aug. 7, 2007 |
| 7244422 |
Vaccines containing ribavirin and methods of use thereof |
Jul. 17, 2007 |
| 7244715 |
Vaccines containing ribavirin and methods of use thereof |
Jul. 17, 2007 |
| 7208523 |
Alanine- and glycine-containing therapeutic agent for hepatitis |
Apr. 24, 2007 |
| 7204989 |
HEV antigenic peptide and methods |
Apr. 17, 2007 |
| 7148323 |
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus |
Dec. 12, 2006 |
| 7037506 |
Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
May. 2, 2006 |
| 7029678 |
Vaccines |
Apr. 18, 2006 |
| 7005130 |
Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E |
Feb. 28, 2006 |
| 6932972 |
Combined vaccine compositions |
Aug. 23, 2005 |
| 6893644 |
Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid A |
May. 17, 2005 |
| 6887484 |
Vaccine composition containing a promoter peptide |
May. 3, 2005 |
| 6881821 |
Hepatitis-C virus type 4, 5, and 6 |
Apr. 19, 2005 |
| 6849429 |
Viral pseudo-capsids including assembly agonists and antagonists |
Feb. 1, 2005 |
| 6828139 |
Production of replicative hepatitis C virus |
Dec. 7, 2004 |
| 6706873 |
Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
Mar. 16, 2004 |
| 6680059 |
Vaccines containing ribavirin and methods of use thereof |
Jan. 20, 2004 |
| 6623739 |
Vaccines |
Sep. 23, 2003 |
| 6596282 |
Treatment of chronic viral infections with M. vaccae |
Jul. 22, 2003 |
| 6586568 |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
Jul. 1, 2003 |
| 6534064 |
Stabilized protein particles for inducing cellular immune responses |
Mar. 18, 2003 |
| 6524589 |
Compositions of hepatitis C virus NS3/NS4A complex and methods for crystallizing same |
Feb. 25, 2003 |
| 6488934 |
Hepatitis B vaccine |
Dec. 3, 2002 |
| 6451320 |
Combined hepatitis and herpesvirus antigen compositions |
Sep. 17, 2002 |
| 6447994 |
Production of replicative hepatitis C virus |
Sep. 10, 2002 |
| 6410009 |
Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
Jun. 25, 2002 |
| 6299874 |
Method of treatment |
Oct. 9, 2001 |
| 6287759 |
Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
Sep. 11, 2001 |
| 6261569 |
Retro-, inverso- and retro-inverso synthetic peptide analogues |
Jul. 17, 2001 |
| 6217858 |
Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
Apr. 17, 2001 |
| 6210901 |
Specific binding substances for antibodies and their use for immunoassays or vaccines |
Apr. 3, 2001 |
| 6153579 |
Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex |
Nov. 28, 2000 |
| 6146643 |
Human/simian chimeric hepatitis A virus vaccine |
Nov. 14, 2000 |
| 6146632 |
Vaccines |
Nov. 14, 2000 |
| 6136320 |
Vaccines expressed in plants |
Oct. 24, 2000 |
| 6117449 |
Method for inducing a systemic immune response to a hepatitis antigen |
Sep. 12, 2000 |
| 6063380 |
Enhanced immunogenic vaccine |
May. 16, 2000 |
| 6051238 |
Stabilizers for lyophilized mumps vaccines |
Apr. 18, 2000 |
| 6020167 |
Composition used as a therapeutic agent against chronic viral hepatic diseases |
Feb. 1, 2000 |
| 5980901 |
Viral defective interfering particles and uses thereof |
Nov. 9, 1999 |
| 5914123 |
Vaccines expressed in plants |
Jun. 22, 1999 |
| 5837269 |
Vaccine compositions and method for enhancing an immune response |
Nov. 17, 1998 |
| 5837260 |
Chimeric hepatitis A vaccine |
Nov. 17, 1998 |
| 5817314 |
Quillaja saponin adjuvant and vaccine formulation containing same |
Oct. 6, 1998 |
| 5770689 |
Hepatitis E virus ORF Z peptides |
Jun. 23, 1998 |
| 5766603 |
Cell culture of hepatitis A virus |
Jun. 16, 1998 |
| 5750112 |
Canine coronavirus vaccine from feline enteric coronavirus |
May. 12, 1998 |
| 5562910 |
Vaccine compositions and method for enhancing an immune response |
Oct. 8, 1996 |
|
|
|
